Subcutaneous immunotherapy (SCIT) is a widely used therapy for allergic rhinitis and asthma. It is a useful adjunct to standard medical management of these conditions that can lead to long-term benefits and possible resolution of symptoms. The benefits of SCIT, particularly for children, include avoiding prolonged use and side effects from medications, preventing new aeroallergen sensitizations, and reducing the risk of developing asthma. The primary risks of SCIT include local and systemic reactions. Standard schedules for SCIT include advancing through multiple doses usually in four vials (diluted to 1:1000) on a weekly basis; however, there are benefits of using accelerated schedules, especially for children who need to coordinate school and parent work schedules. Special considerations for pediatric patients include fear of needles, avoiding discomfort with injections, consent, optimal injection scheduling, and difficulty communicating about symptoms during reactions in very young children. Overall, SCIT can be a safe and beneficial therapy for children.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2500/aap.2022.43.210114 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Clinical efficacy of sublingual immunotherapy for allergic rhinitis].
Nihon Yakurigaku Zasshi
January 2025
Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University.
The prevalence of allergic rhinitis (AR) reached 49.2% in 2019. In particular, the prevalence of Japanese cedar (JC) pollinosis is 38.
View Article and Find Full Text PDFApplication of Nanoparticles for Immunotherapy of Allergic Rhinitis.
Int J Nanomedicine
November 2024
Laboratory Medicine Center, Allergy Center, Department of Transfusion Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, 310014, People's Republic of China.
Article Synopsis
- Allergen Immunotherapy (AIT) is currently the only treatment that targets the root cause of allergic rhinitis (AR), with established methods like subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) showing positive results but also side effects.
- Innovative approaches using nanoparticles (NPs), which are tiny particles (1-100 nm), are being explored as safer and more effective delivery systems for AIT, potentially enhancing immune modulation and drug concentration.
- The review discusses various types of nanoparticle delivery systems, such as chitosan, exosomes, metal, and viral nanoparticles, while highlighting their advantages and limitations, indicating that more research is needed to confirm their effectiveness in treating AR.
Sleep and Immune System Crosstalk: Implications for Inflammatory Homeostasis and Disease Pathogenesis.
Ann Neurosci
September 2024
GloNeuro, Noida, Uttar Pradesh, India.
Background: Sleep and immune function are interconnected aspects of health that mutually impact each other in disease development and inflammatory homeostasis. Different aspects of immunology are regulated by different sleep characteristics, impacting on specific aspects of immune function including cytokine production and T-cell activity. Ongoing disruptions of sleep have been linked to heightened inflammation and are suspected in the pathogenesis and disease course of a range of life-style-related illnesses, including diabetes and neurodegenerative diseases.
View Article and Find Full Text PDFBackground: Allergen immunotherapy (AIT) aims at modulating the immune response by administration of allergen preparations at regular intervals over several years (1). For subcutaneous AIT (SCIT), the treatment is initiated with a dose escalation phase followed by a maintenance dose administration. Over the last decade, there has been a trend towards shortening dose escalation regimens to increase patient adherence.
View Article and Find Full Text PDFAllergen Immunotherapy for a Year Can Effectively Reduce the Risk of Postoperative Recurrence of Adenoid Hypertrophy in Children with Concurrent Allergic Rhinitis (IMPROVEII).
J Asthma Allergy
November 2024
Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Background: Adenoid hypertrophy (AH) and allergic rhinitis (AR) are common pediatric diseases, seriously affecting the quality of life and growth of children. The recurrence rate of AH is higher for patients with than for those without concurrent AR. Allergen specific immunotherapy (AIT) is the only effective therapy for modifying the course of allergic diseases.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!